Loading...
OTCMPRCXF
Market cap63mUSD
May 27, Last price  
0.70USD
Name

Green Cross Health Ltd

Chart & Performance

D1W1MN
OTCM:PRCXF chart
P/E
15.12
P/S
0.35
EPS
0.08
Div Yield, %
48.64%
Shrs. gr., 5y
0.03%
Rev. gr., 5y
-2.34%
Revenues
504m
+2.28%
2,041,0004,019,000393,00030,000239,00011,413,00016,336,000105,541,00099,204,000248,413,000322,478,000447,700,000487,645,000522,909,000567,236,000568,531,000559,611,000666,628,000492,571,000503,813,000
Net income
12m
-74.01%
-76,0001,096,000-6,562,000-570,00061,0003,523,0005,161,0009,939,00013,188,00015,034,00014,425,00017,036,00019,642,00016,784,00016,105,00013,490,00016,752,00024,561,00045,234,00011,757,000
CFO
46m
+3.38%
0000000023,249,00023,246,00021,543,00018,424,00029,918,00033,180,99929,451,00052,514,00069,843,00065,134,00044,456,00045,957,000
Earnings
May 28, 2025

Profile

Green Cross Health Limited provides health care and advice services to communities in New Zealand. It operates through Pharmacy Services and Medical Services segments. The Pharmacy Services segment offers pharmacy services through stores, equity accounted investments, and franchise stores. It operates approximately 345 community pharmacies under the Unichem and Life Pharmacy brands. The Medical Services segment operates owned and equity accounted medical centres; and offers support services provided to its medical centres, as well as medical centres outside the company. It also provides back office and operational services to medical centres; and offers family healthcare services through GP, accident, and medical centres under The Doctors brand. Green Cross Health Limited was incorporated in 1999 and is based in Auckland, New Zealand.
URL
https://www.greencrosshealth.co.nz/
IPO date
Mar 29, 2000
Employees
Domiciled in
NZ
Incorporated in
NZ

Valuation

Title
NZD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑032015‑03
Income
Revenues
503,813
2.28%
492,571
-26.11%
666,628
19.12%
Cost of revenue
476,903
390,283
539,422
Unusual Expense (Income)
NOPBT
26,910
102,288
127,206
NOPBT Margin
5.34%
20.77%
19.08%
Operating Taxes
6,591
6,804
14,292
Tax Rate
24.49%
6.65%
11.24%
NOPAT
20,319
95,484
112,914
Net income
11,757
-74.01%
45,234
84.17%
24,561
46.62%
Dividends
(48,895)
(10,073)
(4,314)
Dividend yield
33.35%
5.19%
2.26%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
15,671
14,928
16,199
Long-term debt
238,550
207,165
194,649
Deferred revenue
Other long-term liabilities
Net debt
224,003
156,731
160,974
Cash flow
Cash from operating activities
45,957
44,456
65,134
CAPEX
(7,399)
(5,714)
(4,090)
Cash from investing activities
(18,176)
5,428
(24,884)
Cash from financing activities
(60,914)
(40,101)
(29,291)
FCF
12,302
91,212
105,012
Balance
Cash
23,402
58,215
45,154
Long term investments
6,816
7,147
4,720
Excess cash
5,027
40,733
16,543
Stockholders' equity
166,608
202,005
173,956
Invested Capital
306,164
284,087
270,594
ROIC
6.88%
34.43%
44.09%
ROCE
8.65%
31.49%
44.30%
EV
Common stock shares outstanding
143,745
143,802
143,650
Price
1.02
-24.44%
1.35
1.50%
1.33
29.13%
Market cap
146,620
-24.47%
194,133
1.61%
191,054
29.44%
EV
382,963
361,461
366,513
EBITDA
47,433
124,374
150,183
EV/EBITDA
8.07
2.91
2.44
Interest
10,274
1,453
701
Interest/NOPBT
38.18%
1.42%
0.55%